Bullying Perpetration and Narcissistic Personality Traits across Adolescence: Joint Trajectories and Childhood Risk Factors

by Farrell, Ann H., Vaillancourt, Tracy
Published in Front Psychiatry (2020)

Flexibility and innovation in the FDA’s novel regulatory approval strategies for hematologic drugs

by Farrell, Ann T., Goldberg, Kirsten B., Pazdur, Richard
Published in Blood (2017)

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events

by Gupta, Harsh V, Farrell, Ann M, Mittal, Manoj K
Published 2014

Effects of daily iron supplementation in primary-school–aged children: systematic review and meta-analysis of randomized controlled trials

by Low, Michael, Farrell, Ann, Biggs, Beverley-Ann, Pasricha, Sant-Rayn
Published 2013

Carbapenem Resistant Enterobacteriaceae and Endoscopy: An Evolving Threat

by O'Horo, John C., Farrell, Ann, Sohail, M. Rizwan, Safdar, Nasia
Published in Am J Infect Control (2016)

Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care

by Bohra, Anuj, Worland, Thomas, Hui, Samuel, Terbah, Ryma, Farrell, Ann, Robertson, Marcus
Published in World J Gastroenterol (2020)

The NOURISH randomised control trial: Positive feeding practices and food preferences in early childhood - a primary prevention program for childhood obesity

by Daniels, Lynne A, Magarey, Anthea, Battistutta, Diana, Nicholson, Jan M, Farrell, Ann, Davidson, Geoffrey, Cleghorn, Geoffrey
Published 2009

Systematic Review with Meta-analysis: Recurrence of Crohn's disease after Total Colectomy with Permanent Ileostomy

by Fumery, Mathurin, Dulai, Parambir S., Meirick, Paul, Farrell, Ann M., Ramamoorthy, Sonia, Sandborn, William J., Singh, Siddharth
Published in Aliment Pharmacol Ther (2016)

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma

by Kasamon, Yvette L., de Claro, R. Angelo, Wang, Yaping, Shen, Yuan Li, Farrell, Ann T., Pazdur, Richard
Published in Oncologist (2017)

An appraisal of published usability evaluations of electronic health records via systematic review

by Ellsworth, Marc A, Dziadzko, Mikhail, O'Horo, John C, Farrell, Ann M, Zhang, Jiajie, Herasevich, Vitaly
Published in J Am Med Inform Assoc (2017)

Effects of Toxic Compounds in Montipora capitata on Exogenous and Endogenous Zooxanthellae Performance and Fertilization Success

by Hagedorn, Mary, Farrell, Ann, Carter, Virginia, Zuchowicz, Nikolas, Johnston, Erika, Padilla-Gamiño, Jacqueline, Gunasekera, Sarath, Paul, Valerie
Published in PLoS One (2015)

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

by Pulte, E. Dianne, Nie, Lei, Gormley, Nicole, Goldberg, Kirsten B., McKee, Amy, Farrell, Ann, Pazdur, Richard
Published in Blood Adv (2018)

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

by Pulte, Elizabeth Dianne, Dmytrijuk, Andrew, Nie, Lei, Goldberg, Kirsten B., McKee, Amy E., Farrell, Ann T., Pazdur, Richard
Published in Oncologist (2018)

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

by Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Mitchell, Shan Sun, Sridhara, Rajeshwari, Pazdur, Richard
Published 2010

In Reply

by Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Sun Mitchell, Shan, Sridhara, Rajeshwari, Pazdur, Richard
Published 2010

FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia

by Norsworthy, Kelly J., Ko, Chia‐Wen, Lee, Jee Eun, Liu, Jiang, John, Christy S., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Published in Oncologist (2018)

U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Re...

by Pulte, E. Dianne, Wroblewski, Tanya, Bloomquist, Erik, Tang, Shenghui, Farrell, Ann, Deisseroth, Albert, McKee, Amy E., Pazdur, Richard
Published in Oncologist (2019)

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome

by Le, Robert Q., Li, Liang, Yuan, Weishi, Shord, Stacy S., Nie, Lei, Habtemariam, Bahru A., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Published in Oncologist (2018)

FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia

by Pulte, E. Dianne, Vallejo, Jonathon, Przepiorka, Donna, Nie, Lei, Farrell, Ann T., Goldberg, Kirsten B., McKee, Amy E., Pazdur, Richard
Published in Oncologist (2018)

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma

by Raju, G.K., Gurumurthi, Karthik, Domike, Reuben, Kazandjian, Dickran, Landgren, Ola, Blumenthal, Gideon M., Farrell, Ann, Pazdur, Richard, Woodcock, Janet
Published in Clin Pharmacol Ther (2017)